Reported 7 months ago
The performance of biotech and medical stocks, which have lagged behind the overall market since last year, is gradually improving, especially in companies related to detection tools in life sciences and medical information technology. With the US inflation data declining but the overall economy remaining stable, the medical industry is expected to attract investors' interest for potential growth after falling behind the market by about 20% last year. The long-term outlook for the healthcare sector remains positive, as trends like healthcare technology innovation and increasing mergers and acquisitions continue to support the industry's stability and growth potential.
Source: YAHOO